KRT8 and carcinoma: Cells from the malignant liver sites included carcinoma cells, marked by KRT8, KRT18, and EPCAM (Puram et al, 2017; Fig 1B) and diverse TME cell populations, including fibroblasts, endothelial cells, and immune cells (Fig 1C).